Copper in Alzheimer disease: Too much, too little, or misplaced?

Free Radical Biology and Medicine

Volumn 52, Issue 4, 2012, Pages 747-748

  Faller, Peter ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CERULOPLASMIN; COPPER;

ALZHEIMER DISEASE; CHELATION THERAPY; COPPER BLOOD LEVEL; COPPER DEFICIENCY; COPPER METABOLISM; HUMAN; MENKES SYNDROME; MINI MENTAL STATE EXAMINATION; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; WILSON DISEASE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CLIOQUINOL; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS; MENKES KINKY HAIR SYNDROME;

EID: 84856218866     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.11.005     Document Type: Note

References (15)

1. B. Halliwell Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97 2006 1634 1658 (Pubitemid 43873658)
2. A. Changela, K. Chen, Y. Xue, J. Holschen, C.E. Outten, T.V. O'Halloran, and A. Mondragon Molecular basis of metal-ion selectivity and zeptomolar sensitivity by CueR Science 301 2003 1383 1387 (Pubitemid 37075815)
3. E. Madsen, and J.D. Gitlin Copper and iron disorders of the brain Annu. Rev. Neurosci. 30 2007 317 337 (Pubitemid 47224759)
4. S. Lutsenko, A. Bhattacharjee, and A.L. Hubbard Copper handling machinery of the brain Metallomics 2 2010 596 608
5. C. Hureau, and P. Faller Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease Biochimie 91 2009 1212 1217
6. Y.H. Hung, A.I. Bush, and R.A. Cherny Copper in the brain and Alzheimer's disease J. Biol. Inorg. Chem. 15 2010 61 76
7. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52 (Pubitemid 28277534)
8. M.A. Deibel, W.D. Ehmann, and W.R. Markesbery Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress J. Neurol. Sci. 143 1996 137 142 (Pubitemid 26402800)
9. M. Schrag, C. Mueller, U. Oyoyo, M.A. Smith, and W.M. Kirsch Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion Prog. Neurobiol. 94 2011 296 306
10. J.F. Quinn, S. Crane, C. Harris, and T.L. Wadsworth Copper in Alzheimer's disease: too much or too little? Expert Rev. Neurother. 9 2009 631 637
11. X. Zhu, B. Su, X. Wang, M.A. Smith, and G. Perry Causes of oxidative stress in Alzheimer disease Cell. Mol. Life Sci. 64 2007 2202 2210 (Pubitemid 47347959)
12. L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames, J. Harrison, C.L. Masters, S. Targum, A.I. Bush, R. Murdoch, J. Wilson, and C.W. Ritchie Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Lancet Neurol. 7 2008 779 786
13. T.U. Hoogenraad Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients Int. J. Alzheimers Dis. 2011 2011 492686
14. L. Bica, P.J. Crouch, R. Cappai, and A.R. White Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease Mol. Biosyst. 5 2009 134 142
15. R. Squitti, G. Barbati, L. Rossi, M. Ventriglia, G. Dal Forno, S. Cesaretti, F. Moffa, I. Caridi, E. Cassetta, P. Pasqualetti, L. Calabrese, D. Lupoi, and P.M. Rossini Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau Neurology 67 2006 76 82 (Pubitemid 44305465)